Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

Table 3 Comparison of logMAR BCVA between Ozurdex and triamcinolone at each follow up visit

	Ozu (n = 20) logmar BCVA-median	Versus baseline; P value	Tri (n = 20) logmar BCVA-median	Versus baseline; P value	Ozu versus Tri P value
Baseline	1.079	–	1.0395	–	0.3920
4 weeks	0.778	0.107*	0.778	0.0107*	0.9071
8 weeks	0.602	0.0352*	0.602	0.0246*	1.0000
12 weeks	0.477	0.0208*	0.477	0.0188*	0.6990
24 weeks	0.477	0.0179*	0.389	0.0142*	0.5828

ISSN: 2056-9920